effect of Transverse abdominal muscle plane block using injection of marcaine 0.25% on patients pain after cesarean section in Rasht ALzahra hospital year 2011

The effect of marcaine on patient' pain after caesarean section

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108203964N2

Enrollment

Registered

2011-12-10

Start date

2011-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, childbirth and the puerperium. Other complications of anesthesia during labour and delivery

Interventions

Intervention 1: 20cc marcaine 0.25% injection on superficial blockage of transverse abdominal muscle into transverse's fascia abdominal muscle and internal oblique's fascia. Intervention 2: 20cc norma

Treatment - Drugs

Placebo

20cc marcaine 0.25% injection on superficial blockage of transverse abdominal muscle into transverse's fascia abdominal muscle and internal oblique's fascia

20cc normal saline injection on superficial blockage of transverse abdominal muscle into transverse's fascia abdominal muscle and internal oblique's fascia

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria are women who are Gravid 1 and with no history of previous surgery. Exclusion criteria are: Administration of pethedine in recovery room; Bleeding; Marcaine and Diclafenac sensitivity; Hypertension; Need for general anesthesia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The effect of marcaine 0.25% and normal saline injection on superficial blockage of transverse abdominal muscle on pain after elective cesarean section done under spinal anesthesia. Timepoint: In 2,4,6,12,24,48 hrs after surgery. Method of measurement: Patients visiting and recording the severity of pain by visual Analog scaling.	—

Secondary

Measure	Time frame
Dosage of Na – diclofenac suppository in patients received marcaine and normal saline. Timepoint: In 2,4,6,12,24,48 hrs after surgery. Method of measurement: Patients visiting and recording dosage of administrated diclofenac.;The interval between the end of surgery and the administration of first dose of analgesic in patients receives marcaine and normal saline. Timepoint: In 2,4,6,12,24,48 hrs after surgery. Method of measurement: Recording the time administration of diclofenac.	—

Measure

Time frame

Dosage of Na – diclofenac suppository in patients received marcaine and normal saline. Timepoint: In 2,4,6,12,24,48 hrs after surgery. Method of measurement: Patients visiting and recording dosage of administrated diclofenac.;The interval between the end of surgery and the administration of first dose of analgesic in patients receives marcaine and normal saline. Timepoint: In 2,4,6,12,24,48 hrs after surgery. Method of measurement: Recording the time administration of diclofenac.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshte Fakoor

Reproductive Health Research center, Guilan University of Medical Sciences

fakoor@gums.ac.ir+98 13 1322 5624

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026